Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan

ConclusionsTrifluridine/tipiracil was more cost-effective than nivolumab for patients with heavily pretreated metastatic gastric cancer.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research